4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-16-051139
Options or other derivatives
- EVP & Chief Commercial Officer acquired 9,520 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Vounatsos Michel · EVP & Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-05-02 | Grant or award : show line 1 in the form Restricted Stock Unit | +9,520 | $0.00 | 2019-05-02 | 9,520 | 9,520 | D |
Loading xslF345X03/form4.xml…